Patents received Jan. 9, 2007 :

Texas Instruments Inc., for "Method for enhancing the visibility of effective address computation in pipelined architectures, No. 7,162,618." Inventors were Edward P. Kuzemchak, Avonmore; Christine M. Cipriani, Wexford; Christophe Favergeon-Borgialli, Nice, France; and Mary P. Luley, Pittsburgh. The present invention relates to verification of software applications ported between differing instruction set architectures and to the debugging of software applications executed on pipeline architectures.

American Power Conversion Corp., for "Software-based watchdog method and apparatus, No. 7,162,714." Inventor was Thomas F. Wenisch, Pittsburgh. The present invention relates to software monitoring processes. More particularly, it relates to watchdog processes, which monitor the operation of other processes and restart the other processes, as necessary, to maintain proper operation.

Patents received Jan. 16, 2007 :

Virginia Tech Intellectual Properties Inc., for "System and method for enhanced wastewater treatment, No. 7,163,629." Inventors were Mohammad Abu-Orf, Pitman, N.J.; Charles D. Blumenschein, Pittsburgh; John T. Novak and Christopher D. Muller, both of Blacksburg, Va.; and Mark Laquidara, Framingham, Mass. The present invention relates generally to wastewater treatment and, more particularly, to utilizing shear energy to promote breakdown of solid constituents of a wastewater stream.

PPG Industries Ohio Inc., for "Method for making solid, ungelled aminoplast cross-linkers, No. 7,163,748." Inventors were Ronald R. Ambrose, Pittsburgh; Thomas A. Cook, Gibsonia; Shengkui Hu, Baden; and Jonathan T. Martz, Glenshaw. The present invention relates to methods for making cross-linking agents based on modified aminoplast resins and to powder coating compositions containing these cross-linking agents.

Teijin Limited, for "Treating agent for Paget's disease of bone, No. 7,163,933." Inventors were Seiichi Ishizuka, Kazuya Takenouchi and Yasuhiro Oue, all of Hino, Japan; Atsushi Imaizumi, Tokyo; and Noriyoshi Kurihara, Sakamuri V. Reddy and G. David Roodman, all of Pittsburgh. The present invention relates to the use of therapeutic agents for Paget's disease of bone, containing a compound which inhibits expression of general transcription factor of steroid hormone receptor as their active moiety. In addition, the present invention provides a method for screening a compound for treatment of Paget's disease of bone.